Navigation Links
Researchers crack the code of the common cold
Date:2/21/2009

Scientists have begun to solve some of the mysteries of the common cold by putting together the pieces of the genetic codes for all the known strains of the human rhinovirus. Researchers at the University of Maryland School of Medicine in Baltimore and colleagues at the University of Wisconsin-Madison have completed the genomic sequences of the viruses and assembled them into a "family tree," which shows how the viruses are related, with their commonalities and differences. The study will be released on the online version of the journal Science (Science Express) at 2 p.m. EST on February 12.

The researchers say this work provides a powerful tool that may lead to the development of the first effective treatments against the common cold.

"There has been no success in developing effective drugs to cure the common cold, which we believe is due to incomplete information about the genetic composition of all these strains," says the study's senior author, Stephen B. Liggett, M.D., professor of medicine and physiology at the University of Maryland School of Medicine and director of its Cardiopulmonary Genomics Program.

"We generally think of colds as a nuisance, but they can be debilitating in the very young and in older individuals, and can trigger asthma attacks at any age. Also, recent studies indicate that early rhinovirus infection in children can program their immune system to develop asthma by adolescence," says Dr. Liggett, who is a pulmonologist and molecular geneticist.

Major discoveries of the study

The researchers found that human rhinoviruses are organized into about 15 small groups that come from distant ancestors. The discovery of these multiple groups explains why a "one drug fits all" approach for anti-viral agents does not work. But, says Dr. Liggett, "Perhaps several anti-viral drugs could be developed, targeted to specific genetic regions of certain groups. The choice of which drug
'/>"/>

Contact: Bill Seiler
bseiler@umm.edu
410-328-8919
University of Maryland Medical Center
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. UCLA researchers identify markers that may predict diabetes in still-healthy people
3. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
4. Bipolar disorder relapses halved by Melbourne researchers
5. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
6. High and mighty: first common height gene identified by researchers behind obesity gene finding
7. Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD
8. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
9. Researchers develop long-lasting growth hormone
10. Jefferson immunology researchers halt lethal rabies infection in brain
11. Purdue researchers develop technology to detect cancer by scanning surface veins

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...HINGTON, Nov. 8 Speaker...conference following the House passage of H.R. 396...e bill passed by a vote of 220 to 215. Below are ...of my colleagues just received a call from the Pre...ulating us on a great victory for the American peo...
(Date:11/8/2009)...HINGTON, Nov. 7 Tonight...e Health Care for America Act, landmark health ref...s access to quality, affordable, stable and secure...ks down on some of the insurance industry,s worst ...ricans and cut the deficit by $104 billion over te...
(Date:11/8/2009)... New book called "Preventing ...by Dr. Roberto Giraldo shows that AIDS is a result...ariety of so-called immune system stressor agents,...al and most of all, emotional. , ...rom Nov. 6 – 8, 2009, cell biologists, physi...
(Date:11/8/2009)... 3D Global Solutions is pleased to...anaging the proposal effort for ReSound who recent...l Hearing Aid contract. The award includes not onl...ment of Defense and other federal agencies. , ... 8, 2009 -- 3D Global Solutions is pleased to anno...
(Date:11/8/2009)... Freeze-drying of biopharmaceutica...uga, Ontario facility. , ...llner, President and CEO of Therapure Biopharma In...very of a commercial scale pharmaceutical grade fr...eeze drying (lyophilization) available for contrac...
Breaking Medicine News(10 mins):Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 3Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2
... COLUMBUS , Ohio The chronic stress that spouses... disease patients may shorten the caregivers, live...uggests. , The research also provides concrete e...ed this month by researchers from Ohio State Unive...
...NION CITY, Calif., Sept. 18 Abaxis, Inc.,(Nasdaq:... point-of-care,blood analysis systems, announced t...present at the 2007 UBS Global Life Science Confer... presentation at, http://www.ibb.ubs.com . Click o...
... PHILADELPHIA − Human white blood cells, en..., could provide a novel therapy for patients with ...lastic leukemia (ALL), according to researchers at...s human B cells, the researchers were able to erad...
...OUNTAIN VIEW, Calif., Sept. 18 Pharsight,Corporat... of software and,strategic services for optimizing...t has filed an application to list its common stoc...r Pharsight," said Shawn,O,Connor, president, CEO,...
...assportMD Offers Safe, Secure & Free Personal Heal...t. 18 News that radio frequency,identification (R... even,cancer -- has the healthcare and personal he...nd non-invasive alternative already exists. Consum...
...onsumers Urged To Use Online Quality Information B...spital, MINNEAPOLIS, Sept. 18 The Leapfrog Group...oday released this year,s results from a,comprehen...rens, Hospitals and Clinics in Minneapolis and St....
Other Medicine News:Health News:Chronic stress can steal years from caregivers' lifetimes 2Health News:Chronic stress can steal years from caregivers' lifetimes 3Health News:Abaxis to Present at the 2007 UBS Global Life Science Conference 2Health News:T vs. B: Re-engineered human T cells effectively target and kill cancerous B cells 2Health News:T vs. B: Re-engineered human T cells effectively target and kill cancerous B cells 3Health News:Pharsight Files Application for Nasdaq Capital Market Listing 2Health News:Pharsight Files Application for Nasdaq Capital Market Listing 3Health News:RFID Implant Cancer Questions Concern Patients 2Health News:Four Minnesota Hospitals Rate High For Patient Safety and Quality 2
(Date:11/8/2009)...ge of Health Care Reform Bill ,, Critical leg...ge for all Americans ,, BOISE, Idaho, Nov. 7...s House of Representatives passed critical health ...care for seniors and end discrimination by insuran... of affordable health coverage. ,, The Afford...
(Date:11/7/2009)... Patients reported C1-esterase inh...y in treating acute swelling attacks at any body l...er, according to data presented today at the 2009 ...gy (ACAAI) Annual Meeting. The results come from a...allel with the ongoing, prospective, open label I...
(Date:11/7/2009)... Most patients with hereditary ang...an oncoming HAE attack giving the patients suffici...rbidity associated with that attack, according to ...an College of Allergy, Asthma & Immunology (AC... such as fatigue and nausea, which occur frequentl...
Breaking Medicine Technology:AARP Idaho Key Vote News Alert 2AARP Idaho Key Vote News Alert 3Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 3Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 2Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 3Harris Corporation Adds Broadband Satellite Data Mode to JTRS Approved Falcon III 28R 29 AN PRC 117G Multiband Manpack Radio 10257 1Harris Corporation Adds Broadband Satellite Data Mode to JTRS Approved Falcon III 28R 29 AN PRC 117G Multiband Manpack Radio 10257 2Harris Corporation Adds Broadband Satellite Data Mode to JTRS Approved Falcon III 28R 29 AN PRC 117G Multiband Manpack Radio 10257 3ESAI provides grant to LA BioMed to investigate long term correction of erectile dysfunction 58855 1ESAI provides grant to LA BioMed to investigate long term correction of erectile dysfunction 58855 2Prostate cancer gives a new outlook on life 58853 1Prostate cancer gives a new outlook on life 58853 2
...ponse Rate to Combination Treatment, FRAZER, Pa.,...today that in a phase 2 study published online tod... of patients with relapsed indolent,B-cell and man... treatment,with TREANDA(R) (bendamustine hydrochlo...on study is one of three studies in patients with ...
...14 MAP,Pharmaceuticals, Inc. (Nasdaq: MAPP ) tod... program to evaluate MAP0004 as a potential treatm...self-administered at home using MAP,Pharmaceutical...prior Phase,2 efficacy study, MAP0004 provided pai...ained through at least 24 hours. The study also,de...
Other Medicine Technology:Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkin's Lymphoma 2Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkin's Lymphoma 3Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkin's Lymphoma 4Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkin's Lymphoma 5MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine 2MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine 3MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine 4
...g; and Zyplast® injectable collagen implants h...hing facial lines, wrinkles and scars and in provi...the skins natural collagen, require minimal proced...re than one million people worldwide have been tre...
Captique™ Hyaluronic Acid Dermal Filler
...ge of non-surgical facial contouring materials. Yo... results for various applications with exceptional...fers superior versatility for a wide variety of no... Long-lasting, Radiesse saves time and money for b...
HEMOCHRON Model 401 Coagulation Monitoring Instrument
Medicine Products: